Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kuvan in young children with PKU
NCT00838435Phase 3Completed
- Sponsor
- BioMarin Pharmaceutical
- Start
- Feb 2009
- Primary completion
- Sep 2018
- Modality
- Allosteric Modulators, Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
A Phase 3 trial of sapropterin in phenylketonuria (PKU), sponsored by BioMarin Pharmaceutical. Started Feb 2009; status: completed.
02
Drugs
sapropterin
03
Conditions
phenylketonuria (PKU)
Beyond the preview
Go deeper on NCT00838435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00838435.